Search

everythinglearnresearchcommunity

for

Search:↓

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

An 8-year-old boy with Recklinghausen's Disease shows various symptoms and is from a family with close genetic ties.

Misdiagnosis led to unnecessary treatment due to a genetic mutation affecting thyroid hormone resistance.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

A new method can quickly and accurately detect drugs in hair.

Neurosteroids affect prolactin levels in sheep differently depending on stress and pregnancy conditions.

Understanding snoRNA regulation may help slow skin aging.

Retinoids may help treat lupus nephritis and reduce steroid use.

The frizzy mouse and hairless rat mutations are due to changes in the Prss8 gene.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Intense pulsed light with radiofrequency showed mixed results in improving quality of life for hidradenitis suppurativa patients, with no clinical improvements.

The combination of the excimer lamp and liquor carbonis detergens is more effective for scalp psoriasis than the lamp alone.

rPanglaoDB helps study rare cell types by merging RNA data, showing fibrocytes aid in healing.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

The mystacial pad's innervation in adult rats is more complex than previously thought.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Remote photobiomodulation improves brain injury outcomes and behavior in rats.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

The document's conclusion cannot be provided because the document is not readable or understandable.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.